Meaningful Innovation Archive

Medtronic Holiday Program Honors Customer on MiniMed 670G System

In December, we held our annual Holiday Program in Minneapolis. Our CEO, Omar Ishrak, says it’s the most important event of the year. It’s a long standing tradition Earl Bakken started many years ago as a way to showcase our Mission. Every year, Medtronic invites patients and physicians who represent many of our business

Preparing for MiniMed 670G System Launch

In September, we announced an incredibly exciting milestone that sent waves through the healthcare industry. The excitement and anticipation that we’ve seen in response to the FDA approval of the MiniMed 670G system is gratifying, both on a personal and professional level. We have the unique opportunity and privilege of introducing the first ever

Frank Buckley Interviews: MiniMed 670G System

KTLA 5 morning news, Frank Buckley, knows firsthand what it means to care for someone with type 1 diabetes. As Frank’s son’s endocrinologist, we discuss the challenges of diabetes, the innovation leading to the MiniMed 670G system approval, and what’s next. MiniMed® 670G System The Medtronic MiniMed 670G system requires a prescription and is

SmartGuard Technology Helps People with Diabetes Worry Less About Lows

Diabetes is a complex disease to manage, and it can be extremely challenging to keep blood sugar levels within an ideal target range. While reducing high blood sugar (hyperglycemia) is important, as it can lead to long-term complications, reducing low blood sugar (hypoglycemia) can be a matter of life or death. Low blood sugar

Breaking News: FDA Approves the MiniMed 670G System, World’s First Hybrid Closed Loop System

This post originally appeared on The LOOP blog on September 28, 2016 written by Karrie Hawbaker. Today we have fantastic news to share – Medtronic has received FDA approval of the world’s first hybrid closed loop system! The MiniMed® 670G system is the most advanced insulin pump and sensor system designed to help people

FDA Approves MiniMed 670G System – World’s First Hybrid Closed Loop System

I have wonderful news to share with you today. I am extremely proud to announce that the FDA has just approved our groundbreaking MiniMed 670G system – the first hybrid closed loop system in the world! This approval is a significant milestone in the history of diabetes management, and a culmination of many years

Hybrid Closed Loop Pivotal Trial Data Published in JAMA

This morning, we announced that data from the pivotal trial of our Hybrid Closed Loop (HCL) system were published in the Journal of the American Medical Association (JAMA) and concurrently presented at the annual meeting of the European Association for the Study of Diabetes (EASD). The data demonstrated the safety of the system and

SmartGuard Technology: Why Systems That Take Action Are Important

Hypoglycemia (low blood glucose) can be very dangerous and is one of the most frightening situations for people with diabetes – particularly during the night when an estimated 57% of people with type 1 diabetes experience a low at least once.[i] Not to mention it impacts their quality of life and takes time out

Patient-Centered Design Process Results in New, User-Friendly MiniMed 630G System

I am thrilled to announce the U.S. launch of the MiniMed 630G system with SmartGuard technology – our most advanced pump platform for people with diabetes in the country. This latest innovation was developed through a collaborative process with the patient community, who provided feedback on features that matter most to people with diabetes.

DreaMed Captures A Physician’s Logic for an Artificial Pancreas Algorithm

In 2015, we took another step forward in the pursuit of developing an artificial pancreas. We joined forces with DreaMed Diabetes, a leading developer of diabetes treatment and management solutions, to incorporate DreaMed’s MD-Logic Artificial Pancreas algorithm into Medtronic’s future closed loop systems. Professor Moshe Phillip, M.D., Chairman and Chief Scientific Officer of DreaMed